Shattuck Labs Inc is a clinical-stage biotechnology company pioneering the development of dual-sided fusion proteins as an entirely new class of biologic medicine. Its product candidate, SL-172154, has been rationally designed to simultaneously inhibit the CD47/SIRPa checkpoint interaction to restor... Shattuck Labs Inc is a clinical-stage biotechnology company pioneering the development of dual-sided fusion proteins as an entirely new class of biologic medicine. Its product candidate, SL-172154, has been rationally designed to simultaneously inhibit the CD47/SIRPa checkpoint interaction to restore an anti-tumor immune response and to activate the CD40 costimulatory receptor to bolster an immune response. Its product candidate, SL-279252, which is being developed in collaboration with Takeda Pharmaceuticals, or Takeda, has been rationally designed to simultaneously inhibit the PD-1/PD-L1 interaction and activate the OX40 receptor. Show more
AUSTIN, TX and DURHAM, NC, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a biotechnology company pioneering the development of novel therapeutics targeting...
– Announced development of SL-325, a first-in-class antagonist antibody to DR3, the receptor for TL1A; IND filing expected in Q3'2025 – – Cash balance of approximately $90M as of September 30...
– Interim clinical data for SL-172154 in combination with azacitidine in TP53 mutant (TP53m) acute myeloid leukemia (AML) and higher-risk myelodysplastic syndromes (HR-MDS) showed only modest...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.02 | -1.81818181818 | 1.1 | 1.19 | 0.94 | 301073 | 1.029512 | CS |
4 | -0.26 | -19.4029850746 | 1.34 | 1.56 | 0.94 | 321228 | 1.18260044 | CS |
12 | -2.5 | -69.8324022346 | 3.58 | 3.95 | 0.94 | 633857 | 1.65985202 | CS |
26 | -6.58 | -85.9007832898 | 7.66 | 7.6601 | 0.94 | 462627 | 2.61330571 | CS |
52 | -1.18 | -52.2123893805 | 2.26 | 11.76 | 0.94 | 749330 | 5.36216354 | CS |
156 | -8.67 | -88.9230769231 | 9.75 | 11.76 | 0.94 | 322926 | 5.17941814 | CS |
260 | -17.53 | -94.1966684578 | 18.61 | 60.5162 | 0.94 | 292448 | 9.38918588 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.